TP53 and cancer: It is also interesting to note that presence of TP53 C-terminal alternative isoforms specific exon-exon junctions in TCGA tumors and in CCLE cancer cell lines is driven in part by tumors with frame shift, nonsense, splice site mutations causing in some cases aberrant C-terminal splicing.